SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000070858-10-000309
Filing Date
2010-06-10
Accepted
2010-06-10 12:15:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 ENZON PHARMACEUTICALS INC 13GA2 enzonpharmaceuticalsinc.htm SC 13G/A 40057
  Complete submission text file 0000070858-10-000309.txt   42675
Mailing Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255
Business Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255 7043868486
BANK OF AMERICA CORP /DE/ (Filed by) CIK: 0000070858 (see all company filings)

IRS No.: 560906609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 10889553
SIC: 2836 Biological Products, (No Diagnostic Substances)